The S&P 500 Just Closed Its Eighth Straight Winning Week. Healthcare Led the Charge.Eight straight weeks. That is where the S&P 500 stands heading into the final trading days of May 2026, with its longest winning streak since 2023 intact and the index up 8.92% year-to-date. The all-time high of 7,230.12, set on May 1, sits within striking distance. The question now is whether the momentum is built on durable fundamentals or whether the market has simply run ahead of itself. ## What Drove Eight Weeks of Gains Five themes have powered the streak. AI infrastructure spending continues to exceed estimates, with Nvidia's $81.6 billion quarter the latest confirmation. The IPO market has reopened meaningfully, with the SpaceX roadshow generating significant investor interest heading into its anticipated June 12 trading date. Corporate earnings broadly came in above expectations. Easing geopolitical tensions, particularly the preliminary U.S.-Iran ceasefire, have reduced the energy price pressure that threatened to push inflation higher. And market breadth has improved significantly, with gains spreading beyond the Magnificent 7 into mid-cap and small-cap names. That last point matters more than it gets credit for. A rally that broadens from seven mega-cap stocks to hundreds of companies is a healthier rally than one that does not. ## Healthcare Led the Charge Within the market, healthcare was among the top-performing sectors in May. The drivers are different from the AI-related technology names. Healthcare spending is relatively insulated from interest rate cycles, and federal spending in the sector is projected to rise. Several oncology names posted strong gains on clinical data, while biotech broadly benefited from a more constructive FDA approval environment under the current administration. CG Oncology (CGON) gained more than 60% year-to-date. ImmunityBio (IBRX) posted the largest total return of any healthcare stock globally, up more than 300% for the year. These are not broad-based moves driven by macro tailwinds. They are company-specific catalysts rewarding investors who did the fundamental work. ## The Risk the Bulls Are Ignoring The same PCE report that confirmed 3.8% inflation this morning is not bullish for equity multiples. If rate hike probabilities continue to climb toward year-end, the expansion in price-to-earnings ratios that has supported this rally becomes harder to sustain. A market trading at elevated valuations is more sensitive to rate repricing than one that is cheap. Eight straight winning weeks also increases the probability of a consolidation, not because the fundamentals are deteriorating, but simply because positioning has gotten stretched. Overbought markets can stay overbought for longer than most expect, but they rarely go in one direction indefinitely. ## Bottom Line Eight consecutive winning weeks and a near-record market. The S&P 500 is up almost 9% year-to-date on AI momentum, improving earnings, and easing geopolitical risk. Healthcare is the sector quietly delivering alpha while attention focuses on tech. The setup is constructive, but the same inflation data that explains the Iran trade also explains why the path higher from here is harder than the path that got us here.